Net Income

The deal with Ahngook Pharm for its GMRx2 single-pill therapy marks a key step in a global strategy validated by recent US FDA approval.

A new report reveals most IT teams are flying blind in complex hybrid clouds. AI is the key to visibility, but security and skills gaps present new hurdles.

After a tense battle with delisting threats, medical technology firm Lifeward has secured its Nasdaq status, clearing the way to refocus on its mission.

The tech firm is launching a new transparent, scenario-based AI to de-risk the multi-billion dollar drug development pipeline. But can it succeed?

Renter network Stake lands $8M and buys UMoveFree, creating an end-to-end AI platform that puts cash back into renters' pockets from search to signing.

As AI reshapes jobs, one career is thriving on human expertise. Discover why luxury travel advising is a resilient, high-earning path for professionals.

A new study validates Noah Medical's robotic bronchoscopy, showing near-perfect accuracy in diagnosing hard-to-reach lung nodules.

Florida powerhouse attorney Amanda Demanda brings her message of resilience and authentic leadership to a national stage at a New York City women's forum.

This fintech isn't just using AI, it's run by it. See how CloudWalk's autonomous agents are driving $1.8M in revenue per employee and rapid global growth.

With a key clinical trial complete, Emboline's new funding aims to commercialize a device designed to make popular heart procedures safer for patients.

Fueled by a relentless acquisition strategy and 13% organic growth, Turpaz Industries' 2025 results vastly outpace rivals, setting a new industry benchmark.

Dr. Yulun Wang, inventor of the first FDA-approved surgical robot, joins AiM Medical Robotics, signaling a major leap forward for MRI-guided brain surgery.

Janus Henderson's board doubles down on the Trian/General Catalyst cash deal, rejecting a rival offer from Macquarie and paving the way for a private future.

Dynacor advances its ethical gold model in Senegal and Ecuador, with eyes on Ghana, navigating new markets and complex regulatory landscapes.

For 10 years, a free tax program has helped Canadians in need access millions in benefits. See how filing taxes is a critical lifeline in the affordability crisis.

The biopharma firm's new dividend policy reflects strong 2025 results and a dual strategy of rewarding shareholders while funding M&A and expansion.

Appliance giant Whirlpool unveils ambitious new emissions goals, validated by SBTi, aiming for a 90% reduction by 2050 and boosting product efficiency.

With a massive new investment, Vima Therapeutics advances a first-in-class oral drug into Phase 2, offering new hope beyond injections and surgery.

A new study validating patient-reported outcomes in HAE is set to standardize clinical trials, strengthening the case for new oral therapies like deucrictibant.

Ingram Micro secures two U.S. patents for its Xvantage platform, using proprietary AI to eliminate friction and redefine speed in the global IT channel.